Vertebrate Antibodies in collaboration with Professor Sam Martin at Aberdeen University have secured a BBSRC SEEDING CATALYST AWARD to support a project on developing assays to monitor the health robustness and monitor infection of aquatic animals. The project will focus on the characterisation of a set of health markers previously identified at Aberdeen University.  Monoclonal antibodies will be generated towards the selected health markers using an optimised method developed by VAL. The antibodies will be used to characterise the protein expression profile by immunohistochemistry and ELISA. Antibodies are then integrated into high throughput assays or point of care kits to facilitate the measuring and charting of the health markers which will prove beneficial in determining disease state or the effectiveness of treatments and the overall health of farmed fish.

Vertebrate Antibodies in collaboration with Professor Sam Martin at Aberdeen University have secured a BBSRC SEEDING CATALYST AWARD to support a project on developing assays to monitor the health robustness and monitor infection of aquatic animals. The project will focus on the characterisation of a set of health markers previously identified at Aberdeen University.  Monoclonal antibodies will be generated towards the selected health markers using an optimised method developed by VAL. The antibodies will be used to characterise the protein expression profile by immunohistochemistry and ELISA. Antibodies are then integrated into high throughput assays or point of care kits to facilitate the measuring and charting of the health markers which will prove beneficial in determining disease state or the effectiveness of treatments and the overall health of farmed fish.

VERTEBRATE ANTIBODIES LTD (VAL) is pleased to announce that it has established a Strategic Alliance with MARINNOVAC LTD, an emerging international company in the field of aquaculture. MARINNOVAC Ltd is a cluster of visionary SMEs specialising in the development of novel vaccines and PCR-based assays for the diagnosis and treatment of a range of fish and shellfish pathogens. The new alliance with MARINNOVAC will tap into VAL expertise in generating high-quality antibodies which will be integrated into a range of immunoassays required for improving diagnosis, therapy and vaccine development.

The products and services resulting from the alliance will help solve global aquaculture industry health management issues.

VERTEBRATE ANTIBODIES LTD (VAL) is delighted to announce a Strategic Alliance with Forsage Holdings Ltd (FH)

Forsage Holdings Ltd is a dynamic and growth focused Irish family owned private Investment Company with investments in established and fast evolving growth businesses, spanning global telecommunications, software technologies and entrepreneurial ventures.

To complement and diversify its existing  portfolio of investments FH has been seeking an opportunity to invest in the fast developing Life Science and Biotech sector and has identified VAL as its preferred initial investment due to VAL’s unique product range,skilled research team, resource facilities and dedicated personnel.

Strategic Alliance :

FH has acquired an initial minority shareholding in VAL and has committed to provide support in the following areas ; commercial, logistical , legal and financial to accelerate and optimise future business development to mutual benefit.